Implantica AG held its AGM and approved all board proposals
The meeting re-elected board members, carried forward net loss, and approved remuneration.
See the latest news and media coverage for Implantica. We track all announcements, press releases, and industry mentions in real time, all in one place.
Developer of implantable medical devices
implantica.comLast updated
In short: Implantica AG expanded its RefluxStop network, achieved positive clinical milestones, and progressed toward U.S. FDA market approval for its device.
The meeting re-elected board members, carried forward net loss, and approved remuneration.
MD Anderson Cancer Center Madrid - Hospiten becomes the 20th in Spain.
Net sales rose 15% to TEUR 857, adjusted gross margin 93%, and cash at MEUR 45.5.
The study shows a 100% probability of cost-effectiveness vs PPIs and MSA, and 97% vs Nissen fundoplication in Italy.
Cash at the end of the period amounted to MEUR 45.5. Implantica will hold a teleconference on 22 May 2026 at 15:00 (CEST) with Peter...
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of...
Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including the innovative RefluxStop® device for the treatment of...
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year...
Track Implantica and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.